Surgical robotics company Medrobotics raised $33.6 million in Series D round of funding from new and existing investors, according to a company statement.
The Raynham, Mass.-based medical device maker, originally known as Cardiorobotics, plans to use the proceeds to prepare regulatory submissions and prepare for commercial launch in the U.S. and Europe, which it expects may begin next year.
Medrobotics is developing its Flex Robotic System, a a multi-link robot for minimally invasive surgical procedures, hoping to "replace open surgical procedures for many parts of the anatomy that are otherwise difficult or previously impossible to reach," the company’s website says.
"The Flex Robotic System will provide transoral single-site access and visualization for surgery in hard-to-reach locations in the throat and voice box," Medrobotics president & CEO Samuel Straface said in prepared remarks. "Minimally invasive surgery has been shown to be more cost-effective and less painful for the patient and also leads to quicker hospital discharge and faster recovery."
